#United States #Needham #Digital Pathology #Evident #Pramana

Evident's New Release: Pramana™ POD Whole Slide Imaging Scanner

In an exciting development for digital pathology, Evident has introduced the Pramana™ POD Whole Slide Imaging (WSI) Scanner, a benchtop solution aimed at small and medium-sized laboratories. Unveiled at Pathology Visions 2026, this scanner is designed to facilitate the creation of reliable, high-quality images with minimal operator intervention.

As pathology labs face rising case numbers and operational challenges, the need for efficient imaging systems that integrate seamlessly into existing workflows has become pressing. The Pramana POD Scanner addresses these requirements by offering an autonomous imaging capability that enhances accessibility to digital pathology, particularly for smaller laboratories that may lack the resources of larger institutions.

Meeting the Challenge of Digital Transformation

Prasanth Perugupalli, Vice President of Digital Pathology at Evident, highlighted that the Pramana WSI technology has already garnered significant acceptance in university clinical laboratories and lab networks across the U.S. He emphasized how this new scanner helps minimize the need for post-imaging quality assurance, thereby reducing associated costs and delays for laboratories of varying sizes.

The scanner's advanced tissue finder, comprehensive label recognition, and automatic focus level selection facilitate consistent imaging outcomes. Its built-in image quality assessment feature ensures that labs can swiftly generate ready-to-use whole slide images while identifying scans that may need further scrutiny. The volumetric imaging ability captures multiple focal levels, providing precise and sharp focus information across the scanned area, achieving a true 40x magnification at 25 slides per hour under defined conditions.

The Pramana series of autonomous WSI scanners is suitable for various imaging applications, including histopathology, fine-needle aspirations, hematology, cytology, and microbiology. This adaptability is essential as scientific advancements continue to progress, while the supporting laboratory infrastructure tends to lag behind.

Adapting to Evolving Laboratory Needs

The Pramana POD Scanner empowers small to medium-sized labs to adjust their imaging capabilities to meet evolving clinical demands without the burden of extensive resource investment. This innovation is a step toward democratizing access to advanced digital pathology tools, enabling more labs to streamline their processes and maintain high standards of patient care.

For additional insights into the Pramana POD Tabletop WSI Scanner, visit EvidentScientific.com.

About Evident

Evident has built a legacy over the past century, establishing itself as a leader in optical precision microscopy through its parent company, Olympus. The company continues to empower scientists, clinicians, and engineers to visualize the previously invisible through cutting-edge imaging solutions that combine renowned optics with groundbreaking digital innovations.

Evident's Life Science portfolio supports research, clinical diagnostics, and education, offering a comprehensive range of imaging techniques, from essential light and dark field microscopy to advanced fluorescence, 4D analysis, and digital pathology. In industrial microscopy, the company delivers precision and flexibility through laser scanning and digital microscopes designed for tasks ranging from routine inspection to complex quality control and manufacturing analysis.

As Evident ushers in a new epoch of discovery, its user-friendly tools aim to help unlock hidden answers and foster exciting breakthroughs in various fields. Headquartered in Tokyo, the company supports operations through R&D centers and production facilities in the U.S., Germany, and China, in addition to global sales offices and service centers.

Important Notice

The Pramana products are for research purposes only and are not intended for diagnostic use. Future clinical availability relies on regulatory clearances, with approval status varying by country. Performance may vary based on sample type and laboratory workflow.